Evidence map›Paper›PMID 40668626›Full record

ArticleBlood advances2025

The immune receptor FcRγ-chain mediates CD36-induced platelet activation and thrombosis by oxidized low-density lipoproteins.

Katie S Wraith, Jawad S Khalil, Ahmed A Aburima, Lih T Cheah, Matthew S Hindle, Martin Berger, Romez Uddin, Hoor Ayub, Mary McKay, Rui-Gang Xu and 4 more

Abstract read
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Katie S WraithBiomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, United Kingdom.ORCID 0009-0000-7515-8492
Jawad S KhalilLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Ahmed A AburimaBiomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, United Kingdom.
Lih T CheahLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Matthew S HindleLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-5633-2034
Martin BergerDepartment of Internal Medicine, University Hospital Aachen, Aachen, Germany.
Romez UddinSchool of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Hoor AyubSchool of Biosciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-1909-2374
Mary McKayLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Rui-Gang XuLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.ORCID 0000-0003-0774-112X
Robert A S AriënsLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-6310-5745
Mark T KearneyLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Michael G TomlinsonSchool of Biosciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-1189-0091
Khalid M NaseemLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThe scavenger receptor CD36 links atherogenic dyslipidemia to platelet hyperactivity and accelerated thrombosis through the binding of oxidized low-density lipoproteins (oxLDL). The signaling mechanism(s) that facilitates CD36 translation of oxidative lipid stress into platelet activation is unclear. We examined the role of immunoreceptor tyrosine-based activation motif (ITAM) adapter proteins in CD36-mediated platelet activity. oxLDL induced the phosphorylation of the ITAM-containing adapter Fc receptor γ-chain (FcRγ) in human and murine platelets. Phosphorylation of FcRγ was blocked by Src family kinase (SFK) inhibitors, mimicked by CD36-specific oxidized phospholipids and ablated in CD36-/- murine platelets. Under basal conditions, a pool of CD36 formed a multiprotein complex that included FcRγ and the SFKs Lyn and Fyn. CD36 ligation by oxLDL resulted in the recruitment, phosphorylation, and activation of the tyrosine kinase Syk. To explore the functional cooperativity of this CD36-FcRγ complex, we used murine platelets deficient in FcRγ. The genetic ablation of FcRγ prevented oxLDL-induced tyrosine phosphorylation of Syk and downstream adapter SLP-76, but not SFKs. Moreover, platelet aggregation, in vitro thrombosis, and in vivo carotid thrombosis stimulated by oxLDL were lost in the absence of FcRγ. This study establishes FcRγ as a first functional coreceptor for CD36 in platelets, which enables lipid platelet hyperactivity and arterial thrombosis.

Indexed as

CD36 AntigensLipoproteins, LDLPlatelet ActivationReceptors, IgGThrombosisAnimalsBlood PlateletsHumansMiceMice, KnockoutPhosphorylationSignal Transductionsrc-Family KinasesCD36 AntigensLipoproteins, LDLoxidized low density lipoproteinReceptors, IgGsrc-Family Kinases

Identifiers

PMID40668626
PMCPMC12661298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.